Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma

doi:10.3748/wjg.v29.i5.890

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5445)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

250

WORD

HTML

2543

Figures (1-2)

309

Tables (1-3)

328

Sum=3481

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

220

Download

603

Sum=823

Publishing Process of This Article

Item

Count

Browse

238

Download

903

Sum=1141

Feb 7, 2023 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Feb 7, 2023; 29(5): 890-903
Published online Feb 7, 2023. doi: 10.3748/wjg.v29.i5.890

Full Size Figure Download Figure

Figure 1 Flow chart of patient screened, recruited, and analyzed in the study (consort diagram). HCC: Hepatocellular carcinoma; NAC: N-acetylcysteine; DEXA: Dexamethasone.

Citation: Simasingha N, Tanasoontrarat W, Claimon T, Sethasine S. Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma. World J Gastroenterol 2023; 29(5): 890-903
URL: https://www.wjgnet.com/1007-9327/full/v29/i5/890.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i5.890